SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-028487
Filing Date
2024-02-08
Accepted
2024-02-08 17:05:05
Documents
21
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d754271d8k.htm   iXBRL 8-K 36880
2 EX-4.1 d754271dex41.htm EX-4.1 81033
3 EX-5.1 d754271dex51.htm EX-5.1 14584
4 EX-10.1 d754271dex101.htm EX-10.1 187492
5 EX-10.2 d754271dex102.htm EX-10.2 44786
6 EX-99.1 d754271dex991.htm EX-99.1 9357
10 GRAPHIC g754271dsp25.jpg GRAPHIC 3353
11 GRAPHIC g754271g0208083916729.jpg GRAPHIC 2895
  Complete submission text file 0001193125-24-028487.txt   611223

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA clsd-20240206.xsd EX-101.SCH 2852
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20240206_lab.xml EX-101.LAB 17993
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20240206_pre.xml EX-101.PRE 11262
22 EXTRACTED XBRL INSTANCE DOCUMENT d754271d8k_htm.xml XML 3647
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 24610034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)